Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-002858-23Phase 3Completed
Phase 3, randomised trial of ropivacaine in postoperative pain (3 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Pain VAS at coughing at H0. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-002858-23.